BackZynerba Pharmaceuticals Overview

Zynerba Pharmaceuticals Total Assets

Track Zynerba Pharmaceuticals's total assets ($40M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$40.48M
↓ 39.59% YoYΔ $-26.53M vs prior year quarter

Peer trimmed avg / median

Loading

Zynerba Pharmaceuticals Total Assets History

Loading

Zynerba Pharmaceuticals vs. peers: Total Assets Comparison

Loading

Zynerba Pharmaceuticals Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Zynerba Pharmaceuticals (ZYNE) FAQ

The latest total assets for ZYNE is $40M as of June 2023. That compares with $67M in the prior-year period — down 39.6% year over year. Investors often review this figure alongside Zynerba Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, ZYNE's total assets moved from $67M to $40M — a 39.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Zynerba Pharmaceuticals's operating scale or balance-sheet position.

A total assets figure of $40M for ZYNE is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ZYNE's total assets ($40M), review year-over-year change from $67M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Zynerba Pharmaceuticals's total assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.